Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover how iodine-catalyzed metal-free synthesis of 3-arylthioimidazo[1,5-a]N-heterocycles solves transition metal contamination risks and improves yield for pharmaceutical intermediates.
Discover a green, high-yield route for S,S-2,8-diazabicyclononane that eliminates expensive reagents and reduces waste, ensuring supply chain stability for moxifloxacin manufacturing.
Solve chiral synthesis challenges with 93% yield and 98:2 er. Our CDMO expertise scales this patent-protected method for stable API supply chains.
Discover a novel tadalafil synthesis method with 91.5% yield, eliminating hazardous piperonal and reducing equipment costs. Ideal for pharma R&D and procurement teams seeking scalable, eco-friendly production.
Discover how copper-catalyzed trifluoromethylation enables efficient quinazolinone synthesis for AChE/BuChE inhibition. Reduce production costs and scale complex molecules with CDMO expertise.
Discover a novel indolocyclopentane synthesis method with >95% yield and 93% ee. Ideal for pharmaceutical R&D targeting PC-3 prostate cancer cells. Scale up with CDMO expertise.
Solve toxic catalyst & high-cost challenges in phosphoalkenyl ester synthesis. Gold-catalyzed method offers 73-85% yield, 50°C mild conditions, and 99% purity for pharma/pesticide supply chains.
Overcome high costs and harsh conditions in 3-amino-2-indolone synthesis. This I2-H2O2 room-temperature method offers 80-90% yields, eliminating metal catalysts and reducing production risks for pharma R&D and procurement.
Solve chiral ligand supply chain risks with this metal-free synthesis. 86% yield, no resolution needed. Contact for custom production.
Solve amine synthesis challenges with 90%+ yield, room-temperature process, and 15x solvent reuse. Reduce waste & costs for pharma supply chains.
Discover how visible light catalysis enables 90% yield 3-alkylquinoxaline-2(1H)-ketone synthesis at room temperature, reducing production costs and safety risks for pharmaceutical intermediates.
Discover how electrochemical catalysis eliminates metal catalysts and harsh conditions in benzyl alcohol production, reducing costs and supply chain risks for pharmaceutical intermediates. Contact us for scalable solutions.
Solve supply chain risks with metal-free, high-yield synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone. Reduce costs and ensure 99% purity for pharma R&D and production.
Discover a one-pot, metal-free synthesis for spiro-oxindole oxirane derivatives with 87-99% yield. Eliminate expensive equipment and accelerate drug discovery.
Solve high-cost chiral catalyst production with 99.5% ee, 80% yield, and no toxic reagents. Scale to 100MT/yr with NINGBO INNO PHARMCHEM.
Solve transition metal catalyst costs and oxidation risks in sulfoxide synthesis. Our CDMO expertise delivers 82% yield o-amino aryl sulfoxides for drug development with 99% purity.
Discover a cost-effective, catalyst-free route to 5-chloro-3-hydroxy-3-difluoroalkyl-indolin-2-one with >99% yield. Eliminate metal contamination risks and scale up efficiently for pharmaceutical intermediates.
Discover a metal-free, scalable synthesis for trifluoromethylated chromanes. Eliminate transition metal residues and reduce production costs. Contact us for GMP-compliant manufacturing.
Overcome moisture sensitivity and noble metal dependency in pyrimidine synthesis. Achieve 50-86% yields with simplified 3-step process for stable API supply chains.
Simplify 1,2,4-triazole synthesis with this iron-catalyzed method. No anhydrous conditions, high yields, and easy scale-up for drug development. Reduce costs and risks.